Page last updated: 2024-10-26

diclofenac and Graves Ophthalmopathy

diclofenac has been researched along with Graves Ophthalmopathy in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloise, W1
Mimura, LY1
Moura, J1
Nicolau, W1
Vondrichova, T1
de Capretz, A1
Parikh, H1
Frenander, C1
Asman, P1
Aberg, M1
Groop, L1
Hallengren, B1
Lantz, M1

Other Studies

2 other studies available for diclofenac and Graves Ophthalmopathy

ArticleYear
Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study.
    Arquivos brasileiros de endocrinologia e metabologia, 2011, Volume: 55, Issue:9

    Topics: Adult; Aged; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Graves Ophthalmopathy; Humans; Male; M

2011
COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
    Thyroid : official journal of the American Thyroid Association, 2007, Volume: 17, Issue:6

    Topics: Adipocytes; Adipogenesis; Cell Differentiation; Cyclooxygenase 2; Dexamethasone; Diclofenac; Gene Ex

2007